Should You Buy or Sell Aurora Cannabis Now?

Aurora Cannabis (NYSE:ACB) released its fourth-quarter results on Sept. 22 and they were yet another disappointment, with the company reporting a loss of 1.9 billion Canadian dollars for the period as impairment charges of CA$1.8 billion weighed heavily on its financials. Net revenue of CA$72.1 million also came in lower than ... Read More

Is It Too Late to Buy Trulieve Cannabis Stock?

Trulieve Cannabis (OTC:TCNNF) is sizzling hot. So far this year, its share price has soared nearly 60%. That’s a far better performance than any other major U.S. or Canadian cannabis producer, and it comes on the heels of Trulieve’s 47% gain last year.  But such tremendous momentum raises the question ... Read More

Better Marijuana Stock to Buy: Cronos or Canopy Growth?

For a long time, Cronos Group (NASDAQ:CRON) was unable to climb higher than third place among Canadian cannabis producers based on market cap. That changed this year, though, with Cronos rising to second-place position thanks to the rapidly deteriorating share price of Aurora Cannabis. Meanwhile, Canopy Growth (NYSE:CGC) has fairly consistently held ... Read More

Better Marijuana Stock to Buy: Cresco Labs or Trulieve?

It wasn’t all that long ago that billion-dollar U.S. cannabis companies were rarer than four-leaf clovers stuck on the horns of unicorns. That’s changed. Cresco Labs (OTC:CRLBF) and Trulieve Cannabis (OTC:TCNNF) are now among several U.S. cannabis companies that sport market caps of $1 billion or more. Trulieve ranks as one ... Read More